Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Finding the Culprit: Combining Cardiac Magnetic Resonance Imaging With Optical Coherence Tomography.

Xenogiannis I, Lin D, Lesser JR, Hall AB, Cavalcante JL, Brilakis ES, Gössl M.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2106-2109. doi: 10.1016/j.jcin.2019.07.035. Epub 2019 Sep 25. No abstract available.

PMID:
31563676
2.

Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification.

Sorajja P, Gössl M, Babaliaros V, Rizik D, Conradi L, Bae R, Burke RF, Schäfer U, Lisko JC, Riley RD, Guyton R, Dumonteil N, Berthoumieu P, Tchetche D, Blanke P, Cavalcante JL, Sun B.

J Am Coll Cardiol. 2019 Sep 17;74(11):1431-1440. doi: 10.1016/j.jacc.2019.07.069.

PMID:
31514943
3.

Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention.

Tajti P, Xenogiannis I, Hall A, Burke MN, Chavez I, Garcia S, Gössl M, Mooney M, Poulose A, Sorajja P, Wang Y, Vemmou E, Nikolakopoulos I, Morley P, Rangan BV, Ungi I, Brilakis ES.

J Invasive Cardiol. 2019 Sep;31(9):253-259.

4.

Transcatheter Mitral Valve Repair of Recurrent Mitral Regurgitation Following Mitral Surgery.

Niikura H, Bae R, Gössl M, Sun B, Mudy K, Sorajja P.

JACC Cardiovasc Interv. 2019 Jul 22;12(14):1395-1397. doi: 10.1016/j.jcin.2019.02.044. No abstract available.

PMID:
31320033
5.

Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.

Megaly M, Garcia S, Anzia LE, Morley P, Garberich R, Gornick CC, Lesser J, Sorajja P, Gössl M, Sengupta J.

J Invasive Cardiol. 2019 Jul;31(7):E177-E183.

6.

Transcatheter therapy for residual mitral regurgitation after MitraClip therapy.

Niikura H, Bae R, Gössl M, Lin D, Jay D, Sorajja P.

EuroIntervention. 2019 Aug 9;15(6):e491-e499. doi: 10.4244/EIJ-D-18-01148.

7.

Transcatheter Mitral Valve Replacement with Tendyne.

Niikura H, Gössl M, Sorajja P.

Interv Cardiol Clin. 2019 Jul;8(3):295-300. doi: 10.1016/j.iccl.2019.02.003. Epub 2019 Apr 6. Review.

PMID:
31078185
8.

Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.

Urbach J, Hou CR, Lesser JR, Stanberry LI, Garberich RF, Caye D, Sorajja P, Gössl M.

Am J Cardiol. 2019 Jul 1;124(1):98-104. doi: 10.1016/j.amjcard.2019.03.043. Epub 2019 Apr 10.

PMID:
31029410
9.

Sleep Deprivation in Cardiology: A Multidisciplinary Survey.

Lobo AS, Sandoval Y, Burke MN, Sorajja P, Mooney M, Traverse J, Henry TD, Chavez I, Gössl M, Lips DL, Bradley SM, Poulose A, Wang Y, Brilakis ES.

J Invasive Cardiol. 2019 Jun;31(6):195-198. Epub 2019 Apr 15.

10.

The Need for Transcatheter Mitral Valve Replacement.

Sorajja P, Cavalcante JL, Gössl M.

J Am Coll Cardiol. 2019 Mar 26;73(11):1247-1249. doi: 10.1016/j.jacc.2018.11.062. No abstract available.

PMID:
30898199
11.

Complementary Transcatheter Therapy for Mitral Regurgitation.

Sorajja P, Bae R, Gössl M, Askew J, Jappe K, Olson S, Schneider L, Sun B.

J Am Coll Cardiol. 2019 Mar 12;73(9):1103-1104. doi: 10.1016/j.jacc.2018.12.035. No abstract available.

PMID:
30846107
12.

Causes and Clinical Outcomes of Patients Who Are Ineligible for Transcatheter Mitral Valve Replacement.

Niikura H, Gössl M, Kshettry V, Olson S, Sun B, Askew J, Stanberry L, Garberich R, Tang L, Lesser J, Bae R, Harris KM, Bradley SM, Sorajja P.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):196-204. doi: 10.1016/j.jcin.2018.10.042.

PMID:
30678799
13.

Coronary revascularization and use of hemodynamic support in acute coronary syndromes.

Xenogiannis I, Tajti P, Burke MN, Chavez I, Gössl M, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Brilakis ES.

Hellenic J Cardiol. 2019 May - Jun;60(3):165-170. doi: 10.1016/j.hjc.2019.01.010. Epub 2019 Jan 21. Review.

14.

MitraClip patient selection: inclusion and exclusion criteria for optimal outcomes.

Gössl M, Sorajja P.

Ann Cardiothorac Surg. 2018 Nov;7(6):771-775. doi: 10.21037/acs.2018.08.04.

15.

MY APPROACH to patients with asymptomatic aortic stenosis (with normal left ventricular ejection fraction).

Gössl M.

Trends Cardiovasc Med. 2019 Jan;29(1):58. doi: 10.1016/j.tcm.2018.10.007. Epub 2018 Oct 19. No abstract available.

PMID:
30585157
16.

Contemporary Reasons and Clinical Outcomes for Patients With Severe, Symptomatic Aortic Stenosis Not Undergoing Aortic Valve Replacement.

Tang L, Gössl M, Ahmed A, Garberich R, Bradley SM, Niikura H, Witt D, Pedersen WR, Bae R, Lesser JR, Harris KM, Sun B, Mudy K, Sorajja P.

Circ Cardiovasc Interv. 2018 Dec;11(12):e007220. doi: 10.1161/CIRCINTERVENTIONS.118.007220.

PMID:
30562084
17.

Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Implantation.

Tang L, Lesser JR, Schneider LM, Burns MR, Gössl M, Garberich R, Niikura H, Witt D, Sorajja P.

Am J Cardiol. 2019 Feb 15;123(4):658-666. doi: 10.1016/j.amjcard.2018.11.012. Epub 2018 Nov 24.

PMID:
30528421
18.

Outcomes of Extracorporeal Membrane Oxygenation Support for Complex High-Risk Elective Percutaneous Coronary Interventions: A Single-Center Experience and Review of the Literature.

Shaukat A, Hryniewicz-Czeneszew K, Sun B, Mudy K, Wilson K, Tajti P, Stanberry L, Garberich R, Sandoval Y, Burke MN, Chavez I, Gössl M, Henry T, Lips D, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Bradley S, Brilakis ES.

J Invasive Cardiol. 2018 Dec;30(12):456-460. Review.

19.

Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: A Prior Sternotomy Is Not the Problem.

Gössl M, Ahmed A.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2217-2219. doi: 10.1016/j.jcin.2018.08.007. Epub 2018 Aug 28. No abstract available.

PMID:
30409279
20.

Quantifying the Costs of Transcatheter Aortic Valve Replacement Hesitancy.

Garcia S, Gössl M, Sorajja P.

J Am Heart Assoc. 2018 Sep 18;7(18):e010610. doi: 10.1161/JAHA.118.010610. No abstract available.

21.

Transcatheter Closure of Complex Ascending Aortic Pseudoaneurysms After Cardiac Surgery.

Tang L, Lesser JR, Gössl M, Burns MR, Schneider LM, Schwartz JG, Niikura H, Jay DB, Sorajja P.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007052. doi: 10.1161/CIRCINTERVENTIONS.118.007052. No abstract available.

PMID:
30354597
22.

Expecting the unexpected: preventing and managing the consequences of coronary perforations.

Tajti P, Xenogiannis I, Chavez I, Gössl M, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Burke MN, Brilakis ES.

Expert Rev Cardiovasc Ther. 2018 Nov;16(11):805-814. doi: 10.1080/14779072.2018.1533402. Epub 2018 Oct 19. Review.

PMID:
30338712
23.

Incidence, predictors, management and outcomes of coronary perforations.

Shaukat A, Tajti P, Sandoval Y, Stanberry L, Garberich R, Nicholas Burke M, Gössl M, Henry T, Mooney M, Sorajja P, Traverse J, Bradley SM, Brilakis ES.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):48-56. doi: 10.1002/ccd.27706. Epub 2018 Oct 12.

PMID:
30312992
24.

Transcatheter closure of an aorto-right ventricular fistula after TAVR.

Niikura H, Schwartz JG, Lin D, Lesser J, Sorajja P, Gössl M.

Cardiovasc Interv Ther. 2019 Jul;34(3):290-292. doi: 10.1007/s12928-018-0549-2. Epub 2018 Sep 28. No abstract available.

PMID:
30267384
25.

Prevalence, Trends, and Outcomes of Higher-Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes.

Iverson A, Stanberry LI, Tajti P, Garberich R, Antos A, Burke MN, Chavez I, Gössl M, Henry TD, Lips D, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Bradley S, Brilakis ES.

Cardiovasc Revasc Med. 2019 Apr;20(4):289-292. doi: 10.1016/j.carrev.2018.07.017. Epub 2018 Jul 20.

PMID:
30054257
26.

Simultaneous deployment of multiple device occluders and the anchor wire technique for a treatment of paravalvular defect of a surgical mitral ring.

Niikura H, Gössl M, Burns M, Tang L, Jay D, Sorajja P.

Cardiovasc Interv Ther. 2019 Apr;34(2):191-193. doi: 10.1007/s12928-018-0535-8. Epub 2018 Jul 13. No abstract available.

PMID:
30006898
27.

Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling.

Megaly M, Saad M, Tajti P, Burke MN, Chavez I, Gössl M, Lips D, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Kohl LP, Bradley SM, Brilakis ES.

J Interv Cardiol. 2018 Oct;31(5):562-571. doi: 10.1111/joic.12538. Epub 2018 Jul 4. Review.

PMID:
29974508
28.

Use of routinely captured echocardiographic data in the diagnosis of severe aortic stenosis.

Bradley SM, Foag K, Monteagudo K, Rush P, Strauss CE, Gössl M, Sorajja P.

Heart. 2019 Jan;105(2):112-116. doi: 10.1136/heartjnl-2018-313269. Epub 2018 Jun 20.

PMID:
29925543
29.

Waiting to Exhale: Transcatheter Repair of Mitral Regurgitation and Survival.

Sorajja P, Gossl M.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006749. doi: 10.1161/CIRCINTERVENTIONS.118.006749. No abstract available.

PMID:
29895604
30.

Impact of sleep deprivation on the outcomes of percutaneous coronary intervention.

Iverson A, Stanberry L, Garberich R, Antos A, Sandoval Y, Burke MN, Chavez I, Gössl M, Henry TD, Lips D, Mooney M, Poulose A, Sorajja P, Traverse J, Wang Y, Bradley S, Brilakis ES.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1118-1125. doi: 10.1002/ccd.27471. Epub 2018 Jan 3.

PMID:
29314592
31.

Improvement in Aortic Valve Area in Patients With Aortic Stenosis Through Use of a New "Hourglass-Shaped" Valvuloplasty Balloon.

Goldenberg E, Pedersen W, Brilakis ES, Mooney M, Gössl M, Poulose A, Murad B, Kolbeck J, Sorajja P.

J Invasive Cardiol. 2017 Dec;29(12):411-415.

PMID:
29207363
32.

Contemporary Arterial Access in the Cardiac Catheterization Laboratory.

Sandoval Y, Burke MN, Lobo AS, Lips DL, Seto AH, Chavez I, Sorajja P, Abu-Fadel MS, Wang Y, Poulouse A, Gössl M, Mooney M, Traverse J, Tierney D, Brilakis ES.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2233-2241. doi: 10.1016/j.jcin.2017.08.058. Review.

33.

Association of Guideline Adherence for Serial Evaluations With Survival and Adverse Clinical Events in Patients With Asymptomatic Severe Aortic Stenosis.

Ahmed A, Sorajja P, Garberich RF, Farivar RS, Harris KM, Gössl M.

JAMA Cardiol. 2017 Oct 1;2(10):1141-1146. doi: 10.1001/jamacardio.2017.2952.

34.

Severe Mitral Annular Calcification: First Experience With Transcatheter Therapy Using a Dedicated Mitral Prosthesis.

Sorajja P, Gössl M, Bae R, Tindell L, Lesser JR, Askew J, Farivar RS.

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1178-1179. doi: 10.1016/j.jcin.2017.03.026. Epub 2017 May 17. No abstract available.

35.

Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.

Alame AJ, Karatasakis A, Karacsonyi J, Danek BA, Sorajja P, Gössl M, Garcia S, Jneid H, Kakouros N, Martinez-Parachini JR, Resendes E, Kalsaria P, Roesle M, Rangan BV, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2017 Sep;29(9):320-326. Epub 2017 Apr 15.

36.

Current Status of Catheter-Based Treatment of Mitral Valve Regurgitation.

Gössl M, Farivar RS, Bae R, Sorajja P.

Curr Cardiol Rep. 2017 May;19(5):38. doi: 10.1007/s11886-017-0852-z. Review.

PMID:
28374178
37.

Maneuvers for technical success with transcatheter mitral valve repair.

Sorajja P, Kanda B, Bae R, Pedersen WA, Gössl M.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):617-626. doi: 10.1002/ccd.26899. Epub 2017 Feb 1.

PMID:
28145608
38.

Prospective Evaluation of the Eyeball Test for Assessing Frailty in Patients With Valvular Heart Disease.

Ahmed A, Sorajja P, Pai A, Plimpton N, Bae R, Pedersen WA, Tindell L, Farivar RS, Harris K, Gössl M.

J Am Coll Cardiol. 2016 Dec 27;68(25):2911-2912. doi: 10.1016/j.jacc.2016.10.016. No abstract available.

39.

Where Are the Boundaries for Transcatheter Valve Therapy?

Sorajja P, Gossl M.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1372-3. doi: 10.1016/j.jcin.2016.05.040. No abstract available.

40.

Pulmonary hypertension in patients undergoing transcatheter aortic valve replacement: discussion of the current evidence.

Gössl M, Kane GC, Mauermann W, Holmes DR.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002253. doi: 10.1161/CIRCINTERVENTIONS.114.002253. No abstract available.

PMID:
26038483
41.

Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis.

Collin J, Gössl M, Matsuo Y, Cilluffo RR, Flammer AJ, Loeffler D, Lennon RJ, Simari RD, Spoon DB, Erbel R, Lerman LO, Khosla S, Lerman A.

Int J Cardiol. 2015 Feb 15;181:57-64. doi: 10.1016/j.ijcard.2014.11.156. Epub 2014 Nov 26.

42.

Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women.

Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A.

Vasc Health Risk Manag. 2014 Aug 26;10:533-8. doi: 10.2147/VHRM.S63580. eCollection 2014.

43.

Left main coronary artery protection during transcatheter aortic valve deployment.

Sarangi S, Rihal CS, Bruce CJ, Greason KL, Gössl M, Nishimura RA, Suri RM.

J Am Coll Cardiol. 2014 Apr 22;63(15):1583. doi: 10.1016/j.jacc.2013.11.061. Epub 2014 Feb 26. No abstract available.

44.

Accelerated coronary plaque progression and endothelial dysfunction: serial volumetric evaluation by IVUS.

Gössl M, Yoon MH, Choi BJ, Rihal C, Tilford JM, Reriani M, Gulati R, Sandhu G, Eeckhout E, Lennon R, Lerman LO, Lerman A.

JACC Cardiovasc Imaging. 2014 Jan;7(1):103-4. doi: 10.1016/j.jcmg.2013.05.020. No abstract available.

45.

Assessment of individual operator performance using a risk-adjustment model for percutaneous coronary interventions.

Gössl M, Rihal CS, Lennon RJ, Singh M.

Mayo Clin Proc. 2013 Nov;88(11):1250-8. doi: 10.1016/j.mayocp.2013.07.017.

PMID:
24182704
46.

Percutaneous treatment of aortic and mitral valve paravalvular regurgitation.

Gössl M, Rihal CS.

Curr Cardiol Rep. 2013 Aug;15(8):388. doi: 10.1007/s11886-013-0388-9. Review.

PMID:
23812837
47.

Failing left ventricle to ascending aorta conduit-Hybrid implantation of a melody valve and NuMed covered stent.

Gössl M, Johnson JN, Hagler DJ.

Catheter Cardiovasc Interv. 2014 Apr 1;83(5):778-81. doi: 10.1002/ccd.25075. Epub 2013 Nov 18.

PMID:
23784974
48.

An update on transcatheter aortic valve replacement.

Gössl M, Holmes DR Jr.

Curr Probl Cardiol. 2013 Jul;38(7):245-83. doi: 10.1016/j.cpcardiol.2013.04.002. Review.

PMID:
23746946
49.

Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis.

Flammer AJ, Gössl M, Li J, Reriani M, Shonyo S, Loeffler D, Herrmann J, Lerman LO, Lerman A.

J Hypertens. 2013 Mar;31(3):632-5. doi: 10.1097/HJH.0b013e32835c6d2d. No abstract available.

PMID:
23615219
50.

Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women.

Peris P, Atkinson EJ, Gössl M, Kane TL, McCready LK, Lerman A, Khosla S, McGregor UI.

Mayo Clin Proc. 2013 Jan;88(1):46-55. doi: 10.1016/j.mayocp.2012.08.019. Epub 2012 Dec 8.

Supplemental Content

Support Center